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Abstract
nd
Objective: Nigeria records it largest outbreak of Lassa fever in 2018, with 416 confirmed cases by 22  
April 2018 affecting 22 states and the Federal Capital Territory (FCT). This study determines the 
descriptive features of Lassa fever in Bauchi, Northeastern Nigeria.
Methods: A retrospective study that encompasses all the suspected and confirmed cases of Lassa fever 
managed in Abubakar Tafawa Balewa University Teaching Hospital (ATBUTH), Bauchi, between 
October 2016 and April 2018. Clinical notes of these patients were used to source information including 
sociodemographic features, clinical characteristics of the presenting illness, laboratory investigations 
results, working diagnosis, line of management, and treatment outcomes. 
Results: A total 127 suspected cases records were reviewed out of which 27(21%) were positive for Lassa 
fever Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) test. Thirteen (48%) of the confirmed 
cases were males and fourteen (51.9%) females giving a male to female ratio of 1:1.08. their ages ranged 
from 1 to 60 years with a mean age of 27.5. Most cases were seen between October and April. Fever was 
the most common clinical presentation, occurring in 23 cases (85%) at presentation. Other clinical 
features were headache 20 cases (74%), bleeding 19 cases (70%), abdominal pain 14 cases (52%), 
Nausea/Vomiting 12 cases (44%), Diarrhoea 11 cases (41%), cough 11 cases (41%), encephalitis 9 cases 
(33%), Chest pain 8 cases (30%), Hypotension 7 cases (26%), Sore throat 5 cases (19%) and Facial and or 
Neck swelling 3 cases (11%). Mortality among the confirmed cases was (44.4%) with all deaths occurring 
within 72hours of presentation and had bleeding and or encephalitis as presenting symptoms.
Conclusion: Lassa fever is relatively common in Bauchi state and affects people of all age groups and 
sexes. Late presentation, bleeding and encephalitis were common features among mortality cases. 
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Caractéristiques descriptives de la fièvre de Lassa à Bauchi, nord-est du 
Nigéria - une revue rétrospective
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Resume
Objectif: Le Nigeria enregistre la plus grande épidémie de fièvre de Lassa en 2018, avec 416 cas 
confirmés au 22 avril 2018, touchant 22 États et le territoire de la capitale fédérale (FCT). Cette étude 
détermine les caractéristiques descriptives de la fièvre de Lassa à Bauchi, dans le nord-est du Nigéria.
Méthodes: Une étude rétrospective qui englobe tous les cas suspects et confirmés de fièvre de Lassa pris 
en charge à l'hôpital universitaire Abubakar Tafawa Balewa (ATBUTH), Bauchi, entre octobre 2016 et 
avril 2018. Les notes cliniques de ces patients ont été utilisées pour obtenir des informations 
sociodémographiques , caractéristiques cliniques de la maladie, résultats des analyses de laboratoire, 
diagnostic fonctionnel, ligne de traitement et résultats du traitement.
Résultats: Un total de 127 cas suspects ont été examinés, parmi lesquels 27 (21%) étaient positifs pour le 
test de réaction en chaîne par polymérase de transcriptase inverse (RT-PCR). Treize (48%) des cas 
confirmés étaient des hommes et quatorze (51,9%) des femmes ayant un ratio hommes / femmes de 1: 
1,08. leurs âges variaient de 1 à 60 ans avec un âge moyen de 27,5 ans. La plupart des cas ont été observés 
entre octobre et avril. La fièvre était la présentation clinique la plus courante, survenant dans 23 cas (85%) 
lors de la présentation. Les autres caractéristiques cliniques étaient les céphalées 20 cas (74%), les 
hémorragies 19 cas (70%), les douleurs abdominales 14 cas (52%), les nausées / vomissements 12 (44%), 
la diarrhée 11 cas (41%), la toux 11 (41%), encéphalite 9 cas (33%), douleur thoracique 8 cas (30%), 
hypotension 7 cas (26%), mal de gorge 5 cas (19%) et gonflement du visage et du cou 3 cas (11%) . La 
mortalité parmi les cas confirmés était (44,4%), tous les décès étant survenus dans les 72 heures suivant la 
présentation et présentant des saignements et / ou une encéphalite présentant des symptômes.
Conclusion: La fièvre de Lassa est relativement fréquente dans l’état de Bauchi et touche des personnes 
de tous âges et de tous sexes. La présentation tardive, l'hémorragie et l'encéphalite étaient des 
caractéristiques courantes parmi les cas de mortalité.
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includes; Reverse transcriptase Polymerase 
Chain Reaction (RT-PCR) a sensitive test for 
virus RNA, with almost 100% sensitivity by the 
third day of illness (13,14). Other diagnostic 
methods are Vero cell cultures examined by 
fluorescent antibody method. ELISA can detect 
Lassa virus antigen and antibody in the serum. 
The ELISA antigen and antibody tests have 88% 
sensitivity and 90% specificity for the presence of 
the infection (15). Immunohistochemistry, 
performed on formalin-fixed tissue specimen can 
be used to make a post-mortem diagnosis. 
Management of Lassa fever in Bauchi is 
facing challenges including; inadequate personal 
protective equipment, the fear of Lassa fever 
among health workers resulting in patient not 
getting optimal care and lack of diagnostic 
facility for Lassa and other viral haemorrhagic 
fevers. Samples are transported to Irrua Specialist 
Teaching Hospital Edo state or National 
Reference laboratory, Abuja for laboratory 
diagnosis taking average of 2-3days to for result 
to be available. 
MATERIALS AND METHODS 
Study setting
The study was carried out in Abubakar 
Tafawa Balewa University Teaching Hospital 
(ATBUTH) Bauchi, Bauchi state located in 
northeastern Nigeria (16). The state has a 
population of 4,653,066 according to 2006 
national census and has 20 local government 
   areas (17). Most of the inhabitants are farmers. 
Bauchi state span two distinctive vegetative 
zones, namely Sudan savannah which covers the 
southern part and Sahel savannah which covers 
the central and northern parts (16). 
This was a retrospective study that 
encompassed all the suspected and confirmed 
cases of Lassa fever managed at ATBUTH, 
Bauchi, between October 2016 and April 2018. 
ATBUTH is the only centre in Bauchi state that 
manages viral haemorrhagic fever cases and thus 
all suspected cases from within the state are 
referred to the centre for further evaluation and 
management. It is one of the tertiary health 
centres owned by federal government of Nigeria 
in the state. 
Clinical notes of all patients presenting 
with clinically suspected Lassa fever from 
October 2016 to March 2018 were used to source 
information including sociodemographic 
features, clinical characteristics of the presenting 
illness, laboratory investigations results, working 
diagnosis, line of management, and treatment 




Lassa fever (LF) is a viral haemorrhagic 
fever caused by the Lassa virus, an enveloped 
single-stranded RNA virus of the family 
arenaviridae (1). It is found in west and central 
Africa and endemic in countries like Sierra 
Leone, Guinea, Liberia, and Nigeria. Lassa fever 
was first recognised in 1969 in the town of Lassa, 
near Maiduguri, Northeastern, Nigeria (2,3,4). A 
viral illness acquired by close contact with the 
viral natural host, a natal multimammate rat 
(Mastomys natalensis), an animal indigenous to 
most areas of sub-Saharan Africa (5), and dwells 
in proximity to human habitations.
Humans acquire the infection by coming 
in contact with urine and, or faeces of the 
multimammate rats and these when dried can be
aerosolised and inhaled, a significant mode of 
transmission (6). Transmission may also occur by 
the rats directly contaminating human food with 
its saliva or excreta and by humans eating the 
Rats (7). Human to human transmission occurs 
through contacts with body fluids and may give 
rise to nosocomial outbreaks affecting health 
workers. Other routes include Sexual and 
transplacental transmission, transmission 
through breast milk is also possible due to viral 
shedding and high level of viraemia (8)
st st
Between 1  January and 21  April 2018, 
Nigeria recorded 1865 suspected cases of Lassa, 
of which 416 were confirmed positive with 105 
deaths among confirmed cases (25.2% case 
 fatality rate). The outbreak affected 22 of 36 
states in the country, 81% from Edo state and 37 
health workers affected with 8 deaths (9). The 
first documented case of Lassa fever in Bauchi 
state was in 2012 (10), since then, more cases 
were recorded yearly affecting seven local 
government areas in the southern parts of the 
state.
In about 80% of cases, Lassa fever is 
mild or has no observable symptoms and 
unapparent infection, diagnosed serologically, is 
common in endemic areas (11). The symptomatic 
patients present with non-specific clinical 
features thus; high index of suspicion is required 
for diagnosis (12). Major clinical features include 
fever, oedema of the neck and/or face, sub-
conjunctival haemorrhage, jaundice, deafness, 
persistent hypotension, spontaneous abortion, 
bleeding from mouth, nose, rectum and/or vagina 
(in about 20% of cases and a late feature) (12). 
Other clinical features are; malaise, headache, 
retrosternal pain, muscle or joint pain, cough, 
sore throat. abdominal pain and diarrhoea.
Diagnostic investigation for Lassa fever 
 
.
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Table 4. Fever was the most common clinical 
presentation, occurring in 23(85%) of patients at 
presentation. Other common clinical features 
were Headache 74%, Bleeding 70%, Abdominal 
pain 52%, Nausea/Vomiting 44%, Diarrhoea 
41%, Cough 41%, Encephalitis 33%, Chest pain 
30%, Hypotension 26%, Sore throat 19% and 
Facial and or Neck swelling 11%. Table 5 
summarized the different sites of bleeding from 
the 70% (19) cases who had bleeding. 
Gastrointestinal bleeding occurred in 47% of the 
cases, epistaxis 32%, conjunctival bleed was 
11%, Gingival bleeding 5% and skin bleeding 
5%. All the 9 cases that presented with 
encephalitis also had bleeding.
All suspected cases of Lassa fever were 
started empirically on intravenous ribavirin while 
awaiting the outcome of Lassa RT-PCR test. The 
patients were screened for other common Febrile 
illnesses in the study area that can present in 
similar fashion such as Malaria and typhoid fever 
in addition to Lassa fever screening and co-
infection addressed accordingly supportive 
management with intravenous fluids, blood 
transfusion and analgesics were also 
administered as indicated. RT-PCR for Lassa 
virus was repeated at the end of 10day course of 
ribavirin and returned negative. 
Mortality among confirmed cases was 
44.4% (12). Figure I and shows the duration of 
symptoms before presentation and treatment 
outcome respectively. All the 12 mortality cases 
died before the third day of admission and 
commencement of ribavirin (seven died on the 
day of presentation and 5 on the second day on 
admission). Average hospital stay for discharged 
cases was 11days.
DISCUSSION 
In this chart review case, 127 suspected 
cases were admitted with clinical features 
suggestive of Lassa fever of which 27 were 
confirmed positive. 
The confirmed cases came from seven 
local government areas located in the southern 
part of the state and are usually seen during the 
harvesting period when farm products are 
brought home to the onset of the next rainy season 
with the cases disappearing with the first few 
showers of rain. Peak incidence was between 
January to April unlike the finding in Sierra 
Leone which shows peaks in the overlap with the 
wet season (May to November) (18). This could 
partly be due to the fact that viral aerosol stability, 
seems to be higher when the humidity is lower (in 
dry season) as explained by Stephenson 
the case note, so if not indicated in the individual 
case notes, certain signs and symptoms of Lassa 
fever were considered to be absent in a given 
patient and If laboratory reports were not 
available for a particular parameter, we assumed 
that the patient was not investigated for that 
parameter. Positive results for Lassa were 
confirmed by RT-PCR. Samples for RT-PCR 
were taken to the National reference laboratory in 
Abuja or Irrua specialist Hospital, Edo state for 
the test.
Notification information for the patients 
with Lassa fever was obtained from the registry 
of viral haemorrhagic fever cases maintained by 
the Infectious diseases and immunology unit of 
the department of internal medicine of the 
hospital.
Ethical clearance for the study was 
obtained from the Abubakar Tafawa Balewa 
University Teaching Hospital ethics and research 
committee. Data collected were stored and 
analyzed using statistical package for social 
services (SPSS) version 20.0. Simple frequency 
distribution of demographic variables was 
generated and presented as frequencies and 
percentages in tables and graph. Numerical 
values were presented as a mean and standard 
deviation, categorical variables were analysed by 
chi-square tests. Statistically, a significant 
association was taken at p<0.05.
RESULTS
During the study period, a total of 127 
suspected cases admitted were studied out of 
which 27(21%) were positive for Lassa fever RT-
PCR test. Thirteen (48%) of the confirmed cases 
were males and fourteen (51.9%) females giving 
a male to female ratio of 1:1.08. their ages ranged 
from 1 to 60 years with mean age of 27.5 ±13.6. 
The age distribution is shown in Table 1 below. 
Table 2 shows the distribution of cases across the 
affected local government areas in Bauchi state, 
which were all located in the southern part of the 
state. One case came from the neighboring 
plateau state.
Two cases (7%) had contact with 
confirmed cases while five (19%) had contact 
with rodents, the remaining 22 (81%) don't know 
if they had contact with rodents or their excreta.
Seasonal Distribution: the cases reviewed 
presented between the months of October 2016 to 
April 2018, the cases rose through November/ 
December to peak in January and April 2018. 
Table 3 summarizes the distribution of cases by 
month and year.
The clinical features are summarized in 
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experiment (19).The affected Local Government 
Areas (southern Bauchi state) are covered by 
distinctive vegetation zone, the Sudan savannah 
 
and belong to the western agricultural zone (16).
The rains start earlier (in April) with highest 
recorded amount of 1300 mm per annum. In 
contrast, the northern part of the state receives the 
rains late, usually around June or July, and 
records the highest amount of 700 mm per 
annum, this is in keeping with the findings of 
Fichet-Calvet et al on risk maps of Lassa fever in 
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presentation, bleeding and encephalitis were 
common features among the mortality cases. 
Early commencement of ribavirin with good 
supportive care improves outcome.
Limitation of the study: Not all symptoms, 
signs and investigation results were documented 
in the case notes by the managing healthcare 
team.
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Fig. 1:  A bar chart showing duration of symptom before presentation and  
treatment outcome. Vertical column shows the number of cases, Blue colored  
bars reflects cases that presents within 7 days of symptom onset while the green  
bar are cases presenting after seven days of symptom onset   




Age category Frequency Percentage 
 0-9 5 18.5 
10-19 4 14.8 
20=29 6 22.2 
30-39 6 22.2 
40-49 4 14.8 
>49 2 7.4 
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Table 2. Summary of distribution of Lassa fever patients across the  
affected local government areas in Bauchi state and the case from plateau state. 
 
Local Government area Frequency Percentage 
 Alkaleri 1 4 
Bauchi 10 37 
Bogoro 1 4 
Dass 3 11 
Ganjuwa 2 7 
Tafawa Balewa 4 15 
Toro 5 19 
plateau 1 4 
Total 27  
 
 
Table 3. Summary of seasonal distribution of patients with  
Lassa fever in Bauchi 
 
Month Frequency Percentage (%) 
 October, 2017 2 7 
November, 2017 2 7 
December, 2017 3 11 
January 7 26 
February 4 15 
March 9 33 
Total 27  
 
 
Table 4. Summary of clinical profiles of Lassa fever cases 
 
Clinical feature Frequency Percentage (%) 
  Fever 23 85% 
 Headache 20 74% 
 Bleeding 19 70% 
Abdominal Pain 14 51% 
 Nausea/Vomiting 12 44% 
Diarrhoea 11 41% 
 Cough 11 41% 
 Encephalitis 9 33% 
 Chest pain 8 30% 
 Hypotension 7 26% 
Sore throat 5 19% 





Table 5: Summary of sites of bleeding in Lassa fever cases 
 
Site of Bleeding Frequency Percentage (%) 
 Epistaxis 8 32 
Gastrointestinal 6 47 
Gingival bleed 1 5 
Conjunctival 7 11 
Skin 1 5 
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